Naraha
“Allkem has a 75% economic interest in the joint venture established with Toyotsu Lithium Corporation (TLC). Despite having significant influence, operational control is exercised by TTC. There is strong domestic demand for hydroxide to enable the production of high-end battery technology and Allkem will strategically market this product with TTC.”
Risks
“the ability to ensure fair, representative and market competitive pricing for LiOH products being sold to Japanese entities that are formally or informally related to TTC.”
..................................................................................................
Its got me stumped what they mean with the highlighted wording (Naraha)?
and
In the Risks section
If the Contracts are drawn up properly there shouldn't be a loophole for TTC to take advantage? and would they throw AKE under the bus?
Ridiculous to have that in the report worded that way unless existing contract wording presents an advantage imo
Md
- Forums
- ASX - By Stock
- AKE
- Ann: FY22 Half Year Report & Accounts
Ann: FY22 Half Year Report & Accounts, page-3
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online